Why the study?
Does low-molecular-weight heparin improve lipoprotein profiles compared to conventional heparin in patients on chronic haemodialysis?
Population
22 patients who had been on chronic haemodialysis for longer than 12 months
Comparison
Low-molecular-weight heparin (LMWH) for 6 months vs Conventional, unfractionated heparin
Design
Cohort
Follow-up
12 months
Authors
Loading...
LMWH was associated with lower total and LDL cholesterol in hemodialysis; leaves open whether this improves outcomes versus conventional heparin.
Does low-molecular-weight heparin improve lipoprotein profiles compared to conventional heparin in patients on chronic haemodialysis?
Long-term use of low-molecular-weight heparin instead of conventional heparin during hemodialysis may improve lipid profiles and reduce cardiovascular risk factors.
Schmitt et al. (1993) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: